Vom 2. bis 5. Juni 2021 fassten unsere Schweizer Rheumaexperten für Sie die praxisrelevantesten Abstracts des EULAR-Kongresses zusammen und kommentierten diese.
Rheumatoid Arthritis
Abstracts
- 02.06.2021 | OP0012 | RA: impact of passive smoking in childhood
- 02.06.2021 | OP0006 | RA: DMARDs and COVID-19
- 03.06.2021 | OP0124 | RA-ILD: Nintedanib
- 03.06.2021 | OP0178 | Air pollution and RA activity
- 05.06.2021 | LB0002 | Covid-19 vaccine safety
- 05.06.2021 | LB0003 | Safety of Covid-19 vaccine
Psoriatic Arthritis
Abstracts
folgen
- 02.06.2021 | OP0010 | Does a healthy microbiome lead to improvement of psoriatic arthritis?
- 03.06.2021 | OP0123 | How safe are JAK inhibitors in real-world clinical practice?
- 04.06.2021 | OP0233 | Do patients with psoriatic arthritis with and without axial involvement respond differently to treatment with a JAK inhibitor?
- 04.06.2021 | OP0229 | New GRAPPA recommendations: Here they are!
- 04.06.2021 | OP0220 | Changes in treatment of PsA since 1999-data from the EUROSPA collaboration
- 05.06.2021 | LB0004 | Secukinumab efficacy in enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA)
Spondyloarthritis
Abstracts
- 02.06.2021 | OP0051 | BASDAI
- 02.06.2021 | OP0052 | Remission of axSpA
- 03.06.2021 | OP0138 | Anti-TNF-tapering
- 03.06.2021 | OP0144 | Upadacitinib: 1-year results
- 03.06.2021 | POS0035 | Undiagnosed Axial spondyloarthritis
- 05.06.2021 | POS0245 | Scores
Vasculitis
Abstracts
- 02.06.2021 | AB0353 | GCA: Adrenal insufficiency
- 02.06.2021 | OP0058 | Indicators of cardio- and cerebrovascular risk
- 02.06.2021 | OP0062 | GCA: B cells
- 02.06.2021 | OP0068 | Takayasu arteritis: Biologics
- 02.06.2021 | AB0380 | GCA: Predicting relapse
- 02.06.2021 | OP0059 | GCA: Mavrilimumab
Connective Tissue Diseases
Abstracts
- 02.06.2021 | OP0008 | Dermatomyositis: RCT with IVIG
- 03.06.2021 | OP0135 | Sjögren’s: RCT on Belimumab and Rituximab
- 03.06.2021 | POS0108 | Biomarker of SLE
- 03.06.2021 | POS0701 | SLE: Anifrolumab
- 03.06.2021 | OP0175 | Systemic Sclerosis: Pregnancy
- 03.06.2021 | POS0054 | Systemic Sclerosis: Impact of Covid-19
Additional Topics (incl. Covid19)
Abstracts
- 02.06.2021 | POS1341 | Checkpoint inhibitors
- 03.06.2021 | POS1209 | COVID-19: Treatment
- 03.06.2021 | POS1255 | SARS-CoV-2 vaccine
- 03.06.2021 | AB0763 | IgG4
- 04.06.2021 | OP0282, OP0284, POS1260 | RTX and COVID-9
- 04.06.2021 | AB0692 | COVID-19 and reactive arthritis
- 04.06.2021 | OP0204 | Urate cristal depositions
- 04.06.2021 | OP0208 | Incident gout and complications
- 05.06.2021 | POS0277 | Novel DMARD for osteoarthritis